Contributors - Bill of Health

If You Give a Law Student a Baby

February 21, 2024February 20, 2024 Bobby Stroup Leave a comment

Editor’s Note: Congratulations, Bobby, and welcome to the world, baby Stroup!

By Bobby Stroup

If you give a law student a baby, they’re going to look for legal risk. And if they live in the Bay State, they’re going to want a class on ‘MILK’ (Massachusetts Infant Legal Knowhow).

Then, after learning about the relevant law and policy, they’re probably going to want to write a legal blog post. They’ll need to do additional research to see how they can legally imitate a popular children’s book. Their research will show that “fair use” allows them to parody the book series by exaggerating its format in a new story. Read More

Photo of Alicia Ely Yamin doing fieldwork courtesy of Marion Brown.

Q&A with PFC Director of Global Health and Rights Project, Alicia Ely Yamin

February 13, 2024February 13, 2024 The Petrie-Flom Center Staff Leave a comment

Alicia Ely Yamin J.D. (1991), M.P.H. (1996), Ph.D. is a Lecturer on Law and the Director of the Global Health and Rights Project at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics (PFC) at Harvard Law School; Adjunct Senior Lecturer on Health Policy and Management at the Harvard TH Chan School of Public Health; and Senior Adviser on Human Rights and Health Policy at the global health justice organization, Partners In Health.

Frequently labelled a scholar-activist, she combines academic research and scholarship that bridges law, development, and public health with grassroots work and policy advocacy. She has lived in seven countries on four continents, and worked with and for local advocacy organizations, including co-founding a program on health and human rights in the Asociación Pro Derechos Humanos (Lima, Peru; 1999).

In the interview below, she shares more about her career and life.

WHOOP and the IRS: How Tax Avoidance Helps Health

February 8, 2024February 8, 2024 Bobby Stroup Leave a comment

By Bobby Stroup

On December 19, WHOOP announced their flagship product (bearing the same name as the company) is now eligible for FSA and HSA spending. This news means customers might use tax deductions to purchase the “wearable” wellness device. Effectively, courtesy of Uncle Sam, Americans can now save money on trying to be like Michael Phelps and Colleen Quigley.

More than merely a discount on a fitness band, this announcement highlights larger issues within federal policymaking. The article here explores how the complexities of the tax code are intertwined with American health care.

Eight Opportunities to Use the Law to Address Social Determinants of Health

February 6, 2024January 30, 2024 Temple University Center for Public Health Law Research Leave a comment

By Jon Larsen and Sterling Johnson

Addressing the opioid crisis cannot stop at providing better access to treatment for opioid use disorder (OUD), expanding and enhancing harm reduction efforts, and reimagining the role of law enforcement, as explored previously in this blog series. The response must go further to make treatment and harm reduction more effective, by acknowledging the opioid epidemic as a reflection of the conditions of the whole society, identifying those conditions, and addressing them head-on. A whole-person response to OUD and other substance use disorders needs a well-coordinated whole-of-government response to address myriad societal issues that are critical to effective drug treatment, including, but not limited to, housing, education, economic development, and tax policy.

Psychedelic drug or psychedelics hallucinogenic drugs and hallucinogens representing states of consciousness and psychology or psychological hallucinating in a 3D illustration style.

What Counts as a Psychedelic?

January 26, 2024January 18, 2024 Vincent Joralemon Leave a comment

By Vincent Joralemon

There is little consensus in defining “psychedelic.” Yet, research on and access to these substances hinges on what gets included in the “psychedelic” umbrella. It is time to talk about why we include (and exclude) particular drugs from this category.

AI, Copyright, and Open Science: Health Implications of the New York Times/OpenAI Lawsuit

January 24, 2024January 22, 2024 Adithi Iyer Leave a comment

By Adithi Iyer

The legal world is atwitter with the developing artificial intelligence (“AI”) copyright cage match between The New York Times and OpenAI. The Times filed its complaint in Manhattan Federal District Court on December 27 accusing OpenAI of unlawfully using its (copyrighted and paywalled) articles to train ChatGPT. OpenAI, in turn, published a sharply-worded response on January 8, claiming that its incorporation of the material for training purposes squarely constitutes fair use. This follows ongoing suits by authors against OpenAI on similar grounds, but the titanic scale of the Times-OpenAI dispute and its application of these issues to media in federal litigation makes it one to watch. While much of the buzz around the case has centered on its intellectual property and First Amendment implications, there may be implications for the health and biotech industries. Here’s a rundown of the major legal questions at play and the health-related stakes for a future decision.

. Group of pregnant women and women with children. Vector illustration

#MaternalHealthAwarenessDay: Three Policies to Push

January 23, 2024January 9, 2024 Joelle Boxer Leave a comment

By Joelle Boxer

Today is Maternal Health Awareness Day, focused on the theme “Access in Crisis.”

“Crisis” is the right word, yet still an understatement. In the U.S., for every 100,000 live births in 2021, nearly 33 pregnant people lost their lives. In Norway, that number was 2. Black and Native American women in the U.S. are particularly at risk, with death rates 2-3 times higher than those of white women, due to structural racism.

What can the law do to prevent these deaths? Medicaid pays for more than 40% of births in the U.S., covering 64% of Black mothers and 66% of Native American mothers. Examining efforts at the federal and state level, I highlight three options, leveraging Medicaid as a policy lever.

Conclusion to the Symposium: From Principles to Practice: Human Rights and Public Health Emergencies

January 18, 2024January 18, 2024 The Petrie-Flom Center Staff Leave a comment

By Timothy Fish Hodgson, Roojin Habibi, and Alicia Ely Yamin

In developing the digital symposium, From Principles to Practice: Human Rights and Public Health Emergencies (which ran from October – December 2023), as editors we endeavored to get scholars, human rights advocates, judges, and policy makers to engage critically with the expert Principles and Guidelines on Human Rights and Public Health Emergencies (the PHE Principles), published by the International Commission of Jurists and the Global Health Law Consortium in May 2023. In doing so, we encouraged contributors to comment on the Principles’ potential usefulness as guidance in addressing real emergency situations, as well as any possible gaps and weaknesses.

While summarizing the entire content of the 13 blogs comprising this symposium in any depth is not possible here, this concluding post will attempt to synthesize some of the major inputs from the contributions. We also provide some of our own observations, as participants in the drafting of the Principles, with the aim of pushing the discussion prompted by the posts forward.

Rows of gold post office boxes with one open mail box.

Plan to See ‘Plan C’ This Year

January 16, 2024January 9, 2024 Joelle Boxer Leave a comment

By Joelle Boxer

Tracy Droz Tragos’ new documentary, “Plan C,” follows the work of a grassroots organization dedicated to improving access to the abortion pill by mail in the U.S., while navigating an increasingly restrictive legal landscape.

There is no better time to hear the perspectives of these patients, providers, and activists. Just last month, the U.S. Supreme Court took on a case to determine the legal status of the pill, also called mifepristone. With a decision expected in June 2024, Tragos’ film shows us what’s at stake.

Disposable syringe isolated on black background.

Six Opportunities to Use the Law to Support Harm Reduction

January 12, 2024January 9, 2024 Temple University Center for Public Health Law Research Leave a comment

By Jon Larsen and Sterling Johnson

Harm reduction in the context of the opioid crisis is focused on preventing overdose and infectious disease transmission by working with people who use drugs without moral judgment. Far too often, the public health imperative of harm reduction is blocked by federal policy, state laws, and other structural barriers anchored in the “war on drugs” that reduce the effectiveness of harm reduction efforts. To maximize the potential of harm reduction requires a whole-of-government approach, involving coordination across levels of government.

As noted in this recent report, “Bringing the W-G approach to bear on a complex problem depends on several components, including agreement as to the problem, understanding the problem, and the causes of the problem. For many involved in government at all levels, the harm reduction challenge unfortunately falls at the first of those hurdles.”

Category: Contributors